Dr. Reddy's Laboratories Limited
RDY
$13.94
-$0.28-1.97%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.61% | -0.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.61% | -0.69% | |||
| Cost of Revenue | -1.45% | 6.81% | |||
| Gross Profit | 4.07% | -5.97% | |||
| SG&A Expenses | 7.84% | -2.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 43.64% | -216.54% | |||
| Total Operating Expenses | 1.48% | 1.85% | |||
| Operating Income | 2.12% | -9.51% | |||
| Income Before Tax | -3.93% | 4.42% | |||
| Income Tax Expenses | 19.75% | -13.24% | |||
| Earnings from Continuing Operations | -10.17% | 10.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 25.67% | -32.20% | |||
| Net Income | -10.02% | 10.05% | |||
| EBIT | 2.12% | -9.51% | |||
| EBITDA | 9.11% | -13.97% | |||
| EPS Basic | -9.91% | 10.06% | |||
| Normalized Basic EPS | -5.69% | 2.62% | |||
| EPS Diluted | -9.88% | 10.07% | |||
| Normalized Diluted EPS | -5.70% | 2.63% | |||
| Average Basic Shares Outstanding | -0.14% | -0.01% | |||
| Average Diluted Shares Outstanding | -0.13% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||